Impaired lung function is associated with systemic inflammation and macrophage activation

European Respiratory Journal

Volumn 45, Issue 2, 2015, Pages 557-559

  Baines, Katherine J ^a,b   Backer, Vibeke ^c   Gibson, Peter G ^a,b   Powel, Heather ^a,b   Porsbjerg, Celeste M ^c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD163 ANTIGEN; INTERLEUKIN 6; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; ARCTIC; BODY MASS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HIGH RISK POPULATION; HUMAN; INDIGENOUS PEOPLE; LETTER; LUNG DISEASE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; WESTERN EUROPE; CARDIOVASCULAR DISEASE; COMPLICATION; CROSS-SECTIONAL STUDY; DENMARK; EPIDEMIOLOGY; ETHNOLOGY; GREENLAND; IMMUNOLOGY; INFLAMMATION; INUIT; LUNG; LUNG FUNCTION TEST; MACROPHAGE; METABOLISM; MIDDLE AGED; MIGRANT; PATHOPHYSIOLOGY; QUESTIONNAIRE; REGISTER;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DENMARK; EMIGRANTS AND IMMIGRANTS; FEMALE; GREENLAND; HUMANS; INFLAMMATION; INTERLEUKIN-6; INUITS; LUNG; LUNG DISEASES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; REGISTRIES; RESPIRATORY FUNCTION TESTS; SURVEYS AND QUESTIONNAIRES;

EID: 84922110203     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00187514     Document Type: Letter

References (15)

1. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-715.
2. Schünemann HJ, Dorn J, Grant BJB, et al. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the buffalo health study. Chest 2000;118:656-664.
3. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 370:741-750.
4. Thorleifsson SJ, Margretardottir OB, Gudmundsson G, et al. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med 2009;103:1548-1553.
5. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature. Chest 2005;127:1952-1959.
6. James AL, Knuiman MW, Divitini ML, et al. Risk factors for respiratory symptoms in adults: The Busselton Health Study. Respirology 2013;18:1256-1260.
7. Gimeno D, Delclos GL, Ferrie JE, et al. Association of CRP and IL-6 with lung function in a middle-aged population initially free from self-reported respiratory problems: the Whitehall II study. Eur J Epidemiol 2011;26:135-144.
8. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-1397.
9. Lowe GD, Rumley A, McMahon AD, et al. Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease. Arterioscler Thromb Vasc Biol 2004;24:1529-1534.
10. Fu JJ, McDonald VM, Gibson PG, et al. Systemic inflammation in older adults with asthma-COPD overlap syndrome. Allergy Asthma Immunol Res 2014;6:316-324.
11. Etzerodt A, Moestrup SK. CD163 and inflammation: biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 2013;18:2352-2363.
12. Backer V, Nepper-Christensen S, Porsbjerg C, et al. Respiratory symptoms in Greenlanders living in Greenland and Denmark: a population-based study. Ann Allergy Asthma Immunol 2004;93:76-82.
13. Etzerodt A, Maniecki MB, Møller K, et al. Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leuk Biol 2010;88:1201-1205.
14. Kowal K, Møller HJ, Dubuske LM, et al. Differential expression of monocyte CD163 in single- and dual-asthmatic responders during allergen-induced bronchoconstriction. Clin Exp Allergy 2006;36:1584-1591.
15. Merali S, Barrero CA, Bowler RP, et al. Analysis of the plasma proteome in COPD: Novel low abundance proteins reflect the severity of lung remodeling. COPD 2014;11:177-189.